A2H7JK fundamentals
An in-depth look to Telix Pharmaceuticals Limited operating, investing, and financing activities
A2H7JK free cash flow for H2 24 is -9.54 M EUR. For 2024, A2H7JK free cash flow was 8.51 M EUR and operating cash flow was 25.72 M EUR.
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '24
Q2 '24
Q3 '24
TTM